ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Session » Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment Poster I: Clinical Aspects and Assessments

Date: Sunday, November 8, 2015

Time: 9:00AM-11:00AM

Meeting: 2015 ACR/ARHP Annual Meeting

Abstract Number: 649
Measures of Health-Related Quality of Life in Psoriatic Arthritis: Are They Sensitive to Both Joint and Skin Aspects?
Abstract Number: 650
ASDAS-Based Remission Was Less Frequent Than Basdai-Based Remission, and Both Were Related to CRP and Smoking in Early Axial Spondyloarthritis
Abstract Number: 651
The Prediction of Long-Term Minimal Disease Activity and Its Benefits in Patients with Psoriatic Arthritis
Abstract Number: 652
The Performance of Different Classification Criteria Sets for Spondyloarthritis in the Worldwide ASAS-Comospa Study
Abstract Number: 653
Clinical Responses and Improvements in Patient-Reported Outcomes Are Associated with Increased Productivity in the Workplace and at Home in Axial Spondyloarthritis Patients Treated with Certolizumab Pegol
Abstract Number: 654
Associations Between Skin Outcomes By Body Area Affected and Health-Related Quality of Life in Patients with Psoriatic Arthritis Treated with Certolizumab Pegol
Abstract Number: 655
Rasch Analysis of the Hospital Anxiety and Depression Scale in Psoriatic Arthritis: Results from the Presta Study.  
Abstract Number: 656
Convergent Construct Validity of PsAID12 in a Psoriatic Arthritis Cohort at Baseline
Abstract Number: 657
Routine Assessment of Patient Index Data 3 Score (RAPID3) and Psoriasis Quality of Life (PQoL-12) Assess Different Domains in Psoriasis (PsO) and Psoriatic Arthritis (PsA) Patients
Abstract Number: 658
Health Related Quality of Life in Psoriatic Arthritis from the Perspective of People Living with the Condition
Abstract Number: 659
Does the Inclusion of Extra-Articular Manifestations Improve Validity of the Self-Administered Comorbidity Questionnaire Modified for Spondyloarthritis (SpA-SCQ)? Results from ASAS-Comospa
Abstract Number: 660
Comparison of the Four Validated Psoriatic Arthritis Screening Tools in Diagnosing Psoriatic Arthritis in Patients with Psoriasis [Compaq Study]
Abstract Number: 661
ASDAS Can be Reliably Calculated When Only the Patient’s Overall Basdai Score Is Available, but Not the Score(S) of Its Individual Component(S)
Abstract Number: 662
Can the New Contest Questionnaire Identify Psoriatic Arthritis in a Primary Care Population?
Abstract Number: 663
Mases Correlates Linearly with Disease Activity and Patient Related Outcomes in Patients with Axial Spondyloarthritis within the Scqm Cohort
Abstract Number: 664
Patient Reported Outcomes and Assessment of the Quality of Life in a Cohort of Patients Affected By Enteropathic Spondyloarthritis: Definitive Results of a Monocentric Prospective Observational Study at One Year
Abstract Number: 665
Construct Validity of Disease Activity for Psoriatic Arthritis Composite Index and Tentative Cut-Off Values in a Cohort of Patients with Psoriatic Arthritis
Abstract Number: 666
Disease Activity Indices and Body Mass Index: Cross-Sectional Analysis of a Large Psoriatic Arthritis Cohort
Abstract Number: 667
Comparison of Patient and Provider Assessments of Response to Therapy for Psoriatic Arthritis
Abstract Number: 668
Pasdas, Cpdai and MDA Evolution in the First 6 Months after Diagnosis of Early Psoriatic Arthritis Patients: Results of the Depar Study
Abstract Number: 669
Assessment of Spinal Mobility in Axial Spondyloarthritis: First Validation Steps of a New Electronic Quantification Tool
Abstract Number: 670
Evaluation of the Predictive Value of Non-Specific Musculoskeletal Symptoms in Preclinical Phases of Psoriatic Arthritis
Abstract Number: 671
Discrepancy Between Patients and Physicians Acceptable Symptomatic States in Axial Spondyloarthritis: Findings from the RAPID-AxSpA Study
Abstract Number: 672
Validity of Ankylosing Spondylitis Diagnoses in the Health Improvement Network
Abstract Number: 673
Characterization of Psoriatic Arthritis [Psa] in a Large, Integrated Health Plan: Demographics, Referral Patterns and Care Management
Abstract Number: 674
Clinical Characteristics of Japanese Patients with Reactive Arthritis Induced By Intravesical BCG Therapy for Bladder Cancer: A 19 Years Two-Center Retrospective Study
Abstract Number: 675
Vitamin D Deficiency in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis. Results of the CARMA Study
Abstract Number: 676
What Proportion of Patients with Psa Fail to Achieve MDA Based on Patient Reported Outcomes? an Analysis from a Prospective, Observational Registry
Abstract Number: 677
Satisfaction in Psoriatic Arthritis Patients Despite Active Joint Disease
Abstract Number: 678
Clinical Characteristics and Disease Activity in Psoriatic Arthritis Patients with Dactylitis or Enthesitis: Results from Corrona Registry
Abstract Number: 679
Patients with Psoriatic Arthritis and Oligoarthritic Subtype Report Higher Disease Burden Than Patients with a Polyarthritic Pattern – Data from the German Collaborative Arthritis Centres
Abstract Number: 680
Variability over Time in Patient-Reported Outcome Measures in Patients with Ankylosing Spondylitis
Abstract Number: 681
Impact of Disease Duration on Patient Reported and Clinical Outcomes in Patients with Ankylosing Spondylitis Treated with Anti-TNF: An Analysis from a Prospective, Observational Registry
Abstract Number: 682
Misalignment Between Physician and Patient Satisfaction with Current Psoriatic Arthritis Treatment
Abstract Number: 683
Referral Strategies for the Early Diagnosis of Axial Spondyloarthritis- a Systematic Review
Abstract Number: 684
Evaluation of Patient Acceptable Symptom State in Patients with Axial Spondylarthritis; Similar Thresholds for Radiographic and Non-Radiographic Subgroups
Abstract Number: 685
Sacroiliitis Misdiagnosed As Spondyloarthritis: Clinical Analysis of 581 Cases
Abstract Number: 686
Does an Educational Leaflet Improve Attendance for Screening for Psoriatic Arthritis?
Abstract Number: 687
Mucosal Dysregulation in First-Degree Relatives of Ankylosing Spondylitis Patients
Abstract Number: 688
Clinical Improvements in Psoriasis and Psoriatic Arthritis with Surgical Weight Loss
Abstract Number: 689
Are Individual or Country Level Socio-Economic Determinants Related to Disease Activity and Self-Reported Physical Function in Patients with Spondyloarthritis – Results from Multi-National Cross-Sectional Study Comospa
Abstract Number: 690
The Impact of Ankylosing Spondylitis in Turkey on Productivity at Work Outside Home and within the Household
Abstract Number: 691
Standards for the Classification of Non-Radiographic Axial Spondyloarthritis: A European Real World Study
Abstract Number: 692
Association Between Improvement in Enthesopathy and Quality of Life: Results from a Phase 3 T in Psoriatic Arthritis Patients
Abstract Number: 693
Clinical and Imaging Features of Reactive Arthritis in Guatemala City
Abstract Number: 694
Quality of Life in Patients with Active Peripheral Spa Is Similarly Impaired As in Other Rheumatic Diseases and Influenced By Disease Activity but Not Disease Duration
Abstract Number: 695
Is a Geriatric Rheumatology Sub-Group Worth Distinguishing? Disease Characteristics  of a Geriatric  Psoriatic Arthritis (Gero PsA) Subgroup Compared with Those of below 45 Years of Age
Abstract Number: 696
Current and Past Smoking Are Associated with Functional Impairement and Increased Disease Activity in Axial Spondyloarthritis: Systematic Review and Meta-Analysis
Abstract Number: 697
Identification Methods for Axial Spondyloarthritis in American Veterans
Abstract Number: 698
Is It Possible to Identify Psoriasis Patients Who Will Develop Axial Disease? Real Life Data from Psart (Psoriatic Arthritis Registry of Turkey)
Abstract Number: 699
Improving Ankylosing Spondylitis Specific Outcomes at 6 Months Utilising a Novel Self-Management Education Program
Abstract Number: 700
Problems of Untranslatability: Example of Turkish Version of Basdai
Abstract Number: 701
Is Skin Disease More Important to Women or Men in the Assessment of Disease Activity in Psoriatic Arthritis?
Abstract Number: 702
Is Skin Disease More Important to Patients or Physicians in the Assessment of Disease Activity in Psoriatic Arthritis?
Abstract Number: 703
Isotretinoin-Induced Spondilartropathy-Related Symptoms: A Prospective Study
Abstract Number: 704
Is Axial Involvement Underestimated in Patients with Psoriatic Arthritis? Data from the Bepas Cohort
Abstract Number: 705
Sex Differences in Psoriatic Arthritis: Evaluation of a Real-Life Cohort of 2,118 Italian Patients Treated with Methotrexate
Abstract Number: 706
Undifferentiated Spondylarthritis May More Frequent in Japanese
Abstract Number: 707
Change of Enthesial Involvement Under Treatment Was Independent from the Therapeutic Strategy in Patients with Axial Spondyloarthritis within the Scqm Cohort
Abstract Number: 708
Development of an Activity Disease Score in Patients with Uveitis
Abstract Number: 709
Progression of Patients with Non-Radiographic Axial Spondyloarthritis to Ankylosing Spondylitis: A Population-Based Cohort Study
Abstract Number: 710
Baseline Characteristics of Early, Delayed, and Non-Responders in a Non-Radiographic Axial Spondyloarthritis Study
Abstract Number: 711
Gender Specific Differences in Ankylosing Spondylitis at Treatment Initiation in Patients Treated with Infliximab or Golimumab
Abstract Number: 712
Factors Associated with Anti-TNF Treatment in a Longitudinally Followed Ankylosing Spondylitis (AS) Cohort
Abstract Number: 713
Clinical and Imaging Efficacy of Etanercept in Early Non-Radiographic Axial Spondyloarthritis: 104-Week Treatment Results
Abstract Number: 714
Baseline MRI and CRP As Predictors of Response to Etanercept in the Management of Patients with Non-Radiographic Axial Spondyloarthritis (nr-axSpA)

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences